Showing results (2171-2180 of 8,030) with videos related to
Sort By:
Pageof 803
Current Medicinal Chemistry|September 23, 2021
Neutrophil/Lymphocyte, Platelet/Lymphocyte, and Monocyte/Lymphocyte Ratios in Mood DisordersDonatella Marazziti, Samuele Torrigiani, Manuel G Carbone, et al.Current Medicinal Chemistry|October 29, 2021
Click Reaction in the Synthesis of Dendrimer Drug-delivery SystemsFernando García-Álvarez, Marcos Martínez-GarcíaCurrent Medicinal Chemistry|April 18, 2022
Translocator Protein 18-kDa: A Promising Target to Treat Neuroinflammation- related Degenerative DiseasesChiara Tremolanti, Lorenzo Germelli, Elisabetta Barresi, et al.Current Medicinal Chemistry|April 11, 2022
Aptamer-based Advances in Skin Cancer ResearchAdrianna Maria Piasek, Paulina Musolf, Anna SobiepanekCurrent Medicinal Chemistry|March 2, 2022
COVID-19 Effects on Geriatric Population and Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccines in the Prevention and Treatment of COVID-19Narasimha M Beeraka, SubbaRao V Tulimilli, Mandya V Greeshma, et al.Current Medicinal Chemistry|February 16, 2022
Perspectives and Prospects on mRNA Vaccine Development for COVID-19Lihui Jin, Zhenyuan Han, Pengjun Zhao, et al.Current Medicinal Chemistry|February 16, 2022
Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative DiseasesTeresa Gianferrara, Eleonora Cescon, Ilenia Grieco, et al.Current Medicinal Chemistry|May 15, 2018
Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory DiseasesMiguel D Ferrer, Carla Busquets-Cortés, Xavier Capó, et al.Current Medicinal Chemistry|May 18, 2018
A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's DiseaseJan Korabecny, Katarina Spilovska, Eva Mezeiova, et al.Current Medicinal Chemistry|May 18, 2018
Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A ReviewWang Liao, Shengnuo Fan, Yuqiu Zheng, et al.Pageof 803